November 25, 2024 Sophia Vida
Breaking News

BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts

Company continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market POMPANO BEACH, Fla., Nov. 25, 2024 – PRISM MediaWire – BioStem Technologies, Inc.  (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced that the … Continue reading “BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts”